Key facts
- This page summarizes Jason E. Estes's Form 4 filing for Bank7 Corp. (BSVN).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 04 Aug 2026, 16:13.
Jason E. Estes - 03 Aug 2026 Form 4 Insider Report for Bank7 Corp. (BSVN)
- Reporting relationship
- Exec. Vice President; CCO
- Issuer ticker
- BSVN
- Reported as of
- 03 Aug 2026
- Net transaction value
- -$124,705
- SEC form
- 4
- Accepted by SEC
- 04 Aug 2026, 16:13:30 UTC
- Prior SEC filing
- 30 Jul 2026
- Source filing
- View source filing
- Reporting owner signature
- John T. Phillips, Attorney-In-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Jason E. Estes filed Form 4 for Bank7 Corp. (BSVN) on 04 Aug 2026.
Change
- Previous filing in this sequence was filed on 30 Jul 2026.
- Current net transaction value: -$124,705.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001752262
Primary reporting owner
Estes Jason E
- Relationship
- Exec. Vice President; CCO
- Address
- 1039 NW 63RD STREET, OKLAHOMA CITY
- Signature
- John T. Phillips, Attorney-In-Fact
- Signature date
- 04 Aug 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BSVN
transaction
Common stock, par value $0.01 per share
Sale
- Transaction value
- $20,500
- Shares
- -400
- Change %
- -0.38%
- Price
- $51.25
- Shares after
- 105,917
- Date
- 03 Aug 2026
- Ownership
- Direct
- Footnotes
- F1, F2, F3, F4, F5
BSVN
transaction
Common stock, par value $0.01 per share
Sale
- Transaction value
- $104,205
- Shares
- -2,077
- Change %
- -2%
- Price
- $50.17
- Shares after
- 103,840
- Date
- 04 Aug 2026
- Ownership
- Direct
- Footnotes
- F1, F2, F3, F4, F5, F6
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 6 footnotes
Footnote F1
Includes 8,198 restricted stock units that vest in three equal installments on July 29, 2027, 2028, and 2029.
Footnote F2
Includes 1,365 restricted stock units. The original grant of 2,047 restricted stock units vests in three equal installments on July 29, 2026, 2027, and 2028.
Footnote F3
Includes 26,250 restricted stock units. The original grant of 30,000 restricted stock units vests in eight equal installments on July 29, 2026, 2027, 2028, 2029, 2030, 2031, 2032, and 2033.
Footnote F4
Includes 4,035 restricted stock units. The original grant of 6,052 restricted stock units vests in three equal installments on February 15, 2026, 2027, and 2028.
Footnote F5
Includes 2,549 restricted stock units. The original grant of 7,647 restricted stock units vests in three equal installments on February 15, 2025, 2026, and 2027.
Footnote F6
The price reported is a weighted average. The shares were sold in multiple transactions at prices ranging from $50.00 to $50.34. Upon request, the reporting person will provide the SEC, the company, or any stockholder full information regarding the number of shares sold at each separate price in the range.